Profil
Steve Westing has been Vice President of Medical and Scientific Development for OccuLogix, Inc. since April 10, 2006.
Previously, he was Associate Director-Advisory and Thought Leader Services and a Member of the Ophthalmology Commercial Strategy Team for Genentech, Inc. Prior to joining Genentech in May 1996, Dr. Westing worked at Loredan Biomedical, Inc. since May 1990.
He received a PhD in Muscle Physiology from The Karolinska Institute, Stockholm, Sweden.
Ehemalige bekannte Positionen von Steve Westing
| Unternehmen | Position | Ende |
|---|---|---|
| TEARLAB CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 09.01.2008 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Ausbildung von Steve Westing
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
TearLab Corp., Inc.
TearLab Corp., Inc. Medical SpecialtiesHealth Technology Develops point-of-care portable devices for measuring osmolarity to treat eye disorders | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















